يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Leif Oltedal"', وقت الاستعلام: 0.94s تنقيح النتائج
  1. 1
    Feasibility of deep learning-based tumor segmentation for target delineation and response assessment in grade-4 glioma using multi-parametric MRI

    المؤلفون: Marianne H Hannisdal, Dorota Goplen, Saruar Alam, Judit Haasz, Leif Oltedal, Mohummad A Rahman, Cecilie Brekke Rygh, Stein Atle Lie, Arvid Lundervold, Martha Chekenya

    المصدر: Neuro-Oncology Advances. 5

    مصطلحات موضوعية: Oncology, Surgery, Neurology (clinical)

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::983fd525e8902153e44f0bbd184f003dTest
    https://doi.org/10.1093/noajnl/vdad037Test


    أضف إلى المفضلة
  2. 2
    Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study

    المؤلفون: Marianne Hannisdal, Dorota Goplen, Cecilie Brekke Rygh, Eirik Bratland, Stein Atle Lie, Mohummad Aminur Rahman, Arvid Lundervold, Victoria Smith Arnesen, Jorunn Brekke, Martha Chekenya, Petter Brandal, Judit Haász, Hrvoje Miletic, Lars Herfindal, Leif Oltedal, Andreas Waha, Andrea Gras Navarro

    المصدر: Immunity, Inflammation and Disease
    Immunity,Inflammation and Disease
    Immunity, Inflammation and Disease, Vol 8, Iss 3, Pp 342-359 (2020)

    مصطلحات موضوعية: 0301 basic medicine, Oncology, lcsh:Immunologic diseases. Allergy, Adult, Male, medicine.medical_specialty, recurrent GBM, Immunology, temozolomide, 03 medical and health sciences, 0302 clinical medicine, Immune system, Internal medicine, medicine, Immunology and Allergy, Humans, Adverse effect, immune checkpoint, Antineoplastic Agents, Alkylating, Interleukin 4, Original Research, Temozolomide, Bortezomib, business.industry, bortezomib, Middle Aged, Immune checkpoint, Blockade, Dacarbazine, Drug Combinations, 030104 developmental biology, Th1/Th2 cytokine ratios, Quality of Life, Female, Neoplasm Recurrence, Local, business, lcsh:RC581-607, MGMT, Glioblastoma, Ex vivo, 030215 immunology, medicine.drug

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e82af2c755744d9ceaecb8c07b7fa70Test
    http://europepmc.org/articles/PMC7416034Test


    أضف إلى المفضلة
  3. 3
    Development and validation of a multimodal neuroimaging biomarker for electroconvulsive therapy outcome in depression: a multicenter machine learning analysis

    المؤلفون: Mike van Verseveld, Indira Tendolkar, Eric van Exel, Randall Espinoza, Samadrita Chowdhury, Peter F.A. Mulders, Miklos Argyelan, Christopher C. Abbott, Philip van Eijndhoven, Joan A. Camprodon, Tracy Barbour, Mardien L. Oudega, Annemiek Dols, Guido van Wingen, D Rhebergen, Willem B Bruin, Benjamin Wade, Hauke Bartsch, Katherine L. Narr, Jeroen A. van Waarde, Leif Oltedal, Freek ten Doesschate

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, Modalities, business.industry, medicine.medical_treatment, Area under the curve, medicine.disease, Clinical decision support system, Electroconvulsive therapy, Neuroimaging, Internal medicine, medicine, Biomarker (medicine), Adverse effect, business, Treatment-resistant depression

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8b6b497f51eeff834cebfd60365567e8Test
    https://doi.org/10.1101/2021.07.29.21261206Test


    أضف إلى المفضلة
  4. 4
    Abstract CT114: BORTEM-17 - phase IB/II single arm, non-randomized controlled multicenter study investigating whether sequential bortezomib and temozolomide is safe and effective in recurrent GBM with unmethylated MGMT promoter

    المؤلفون: Dorota Goplen, Mohummad Aminur Rahman, Jorunn Brekke, Victoria Arnesen, Anne Simonsen, Andreas Waha, Kirstin Marienhagen, Leif Oltedal, Judit Haasz, Hrvoje Miletic, Tora Skeidsvoll Solheim, Petter Brandal, Stein Atle Lie, Martha Chekenya

    المصدر: Cancer Research. 82:CT114-CT114

    مصطلحات موضوعية: Cancer Research, Oncology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2fd8d05c2e32e49cc9e80610fe4bda5bTest
    https://doi.org/10.1158/1538-7445.am2022-ct114Test


    أضف إلى المفضلة
  5. 5
    Bortezomib sensitization of recurrent glioblastoma with unmethylated MGMT promoter to temozolomide, a phase II study (NCT03643549)

    المؤلفون: Dorota Goplen, Mohummad Aminur Rahman, Jorunn Brekke, Victoria Smith Arnesen, Anne Simonsen, Andreas Waha, Kirsten Marienhagen, Leif Oltedal, Judit Haasz, Hrvoje Miletic, Tora Skeidsvoll Solheim, Petter Brandal, Stein Atle Lie, Martha Chekenya

    المصدر: Journal of Clinical Oncology. 40:TPS2081-TPS2081

    مصطلحات موضوعية: Cancer Research, Oncology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::921fbf310c2d575a7a8ffd73a3985360Test
    https://doi.org/10.1200/jco.2022.40.16_suppl.tps2081Test


    أضف إلى المفضلة
  6. 6
    P14.09 BORTEM-17: A Phase IB/II Single-Arm, Control Non-Randomized, Multicentre, Open Label Clinical Trial for Recurrent Glioblastoma with unmethylated MGMT promoter (NCT03643549)

    المؤلفون: Stein Atle Lie, Jorunn Brekke, Petter Brandal, Judit Haász, Victoria Smith Arnesen, Anne Simonsen, Dorota Goplen, Martha Chekenya, T. S. Solheim, Hrvoje Miletic, K. Marienhagen, W. Andreas, Leif Oltedal, Mohummad Aminur Rahman

    المصدر: Neuro-Oncology

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, Temozolomide, Performance status, business.industry, Bortezomib, Standard treatment, medicine.medical_treatment, Clinical trial, Poster Presentations, Internal medicine, medicine, P14 Clinical neuro-oncology, AcademicSubjects/MED00300, AcademicSubjects/MED00310, Neurology (clinical), Progression-free survival, business, Adverse effect, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae64627602edfb647bf8b72ec9249883Test
    http://europepmc.org/articles/PMC8427365Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث